Audiologists have known about the ototoxicity of quinine (and its derivatives) and antibiotics (macrolide and aminoglycoside) for decades. But we have never seen the combined use of two drugs, each with known ototoxic potential, being used as an intervention strategy for the coronavirus pandemic (COVID-19).
In an effort to combat the coronavirus (COVID-19), front-line physicians are repurposing two drugs: hydroxychloroquine (commonly used for malaria and rheumatoid arthritis) and azithromycin (a macrolide antibiotic used to treat common infections of the respiratory system, the ear and the eye). Both drugs are known ototoxic agents; however, there is no published research about the synergistic ototoxic effects of these drugs in treating COVID-19.
At the present time, it is not known if hearing loss and/or tinnitus will be a late onset side effect of this COVID-19 drug intervention. Therefore, case history questions will need to be added to accommodate this new population of patients.
Related Posts
What Exactly Are Binaural Beats?
When you present one tone to one ear and a second to the other ear, your brain perceives an additional tone. This is the essence of binaural beats. The concept of two tones creating a third tone should ring familiar with audiologists. However, our clinical use typically is unilateral when assessing distortion product otoacoustic emissions….
Does Your Dog Listen to You?
Dogs have a reputation for being human’s best friend. If you have ever had one as a pet, you know that they can be a loyal companion. Maybe even a trusted confidante? You may have tried training your dog to follow basic commands like “sit” and “stay.” Have you ever noticed though that some…
Who’s Afraid of Snakes?
Research shows that approximately half of the population feel “anxious” about snakes, and a whopping three percent of the population meet the diagnostic criteria for snake phobia (Polak et al., 2016). Is it their skin? Is it that they have no legs and thus slither? Is it the tongue? Is it their ears? Wait—do snakes…